PMID- 35501928 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2524-7948 (Electronic) IS - 2524-7948 (Linking) VI - 4 IP - 1 DP - 2022 May 3 TI - Incidence and risk factors for acute kidney injury after total joint arthroplasty. PG - 18 LID - 10.1186/s42836-022-00120-z [doi] LID - 18 AB - BACKGROUND: Acute kidney injury (AKI) is one of the most common medical causes for readmission following total joint arthroplasty (TJA). This study aimed to (1) examine whether the incidence of AKI has changed over the past decade with the adoption of modern perioperative care pathways and (2) identify the risk factors and concomitant adverse events (AEs) associated with AKI. METHODS: 535,291 primary TJA procedures from the American College of Surgeons National Surgical Quality Improvement Program from 2011 to 2018 were retrospectively reviewed. The annual incidence of AKI was analyzed for significant changes over time. Matched cohort analyses were performed to identify the risk factors and AEs associated with AKI using multivariate logistic regression. RESULTS: The mean incidence of AKI was 0.051%, which remained unchanged during the study period (P = 0.121). Factors associated with AKI were diabetes (OR 1.96, P = 0.009), bilateral procedure (OR 6.93, P = 0.030), lower preoperative hematocrit level (OR 1.09, P = 0.015), body mass index (OR 1.04, P = 0.025), and higher preoperative BUN (OR 1.03, P = 0.043). AKI was associated with length of stay (LOS) > 2 days (OR 4.73, P < 0.001), non-home discharge (OR 0.25, P < 0.001), 30-day readmission (OR 12.29, P < 0.001), and mortality (OR 130.7, P < 0.001). CONCLUSIONS: The incidence of AKI has not changed over the past decade, and it remains a major bundle buster resulting in greater LOS, non-home discharge, readmissions, and mortality. Avoidance of bilateral TJA in patients with DM and high BMI as well as preoperative optimization of anemia and BUN levels are advised. CI - (c) 2022. The Author(s). FAU - Hung, Chun Wai AU - Hung CW AD - Department of Orthopedic Surgery, Baylor College of Medicine, Houston, TX, USA. FAU - Zhang, Theodore S AU - Zhang TS AD - Baylor College of Medicine, Houston, TX, USA. FAU - Harrington, Melvyn A AU - Harrington MA AD - Department of Orthopedic Surgery, Baylor College of Medicine, Houston, TX, USA. FAU - Halawi, Mohamad J AU - Halawi MJ AD - Department of Orthopedic Surgery, Baylor College of Medicine, Houston, TX, USA. mohamad.halawi@bcm.edu. LA - eng PT - Journal Article DEP - 20220503 PL - England TA - Arthroplasty JT - Arthroplasty (London, England) JID - 101773073 PMC - PMC9063071 OTO - NOTNLM OT - Acute kidney injury OT - Arthroplasty OT - Bundle buster OT - Incidence OT - Optimization COIS- Chun Wai Hung and Theodore Zhang have no competing interests to disclose. Melvyn Harrington receives consulting fees from Zimmer, Inc. and is a board member of the J Robert Gladden Orthopaedic Society and the Arthritis Foundation Houston Community Leadership Board, but none of these have a direct competing interest with the current study. Mohammad Halawi has received grants from the J Robert Gladden Orthopaedic Society and the Connecticut Convergence Institute for Translation in Regenerative Engineering, as well as serving leadership positions with the American Orthopaedic Association, the American Association of Hip and Knee Surgeons, and the Journal of Bone and Joint Surgery; none of these serve as a direct competing interest with the current study. EDAT- 2022/05/04 06:00 MHDA- 2022/05/04 06:01 PMCR- 2022/05/03 CRDT- 2022/05/03 00:17 PHST- 2022/02/15 00:00 [received] PHST- 2022/03/13 00:00 [accepted] PHST- 2022/05/03 00:17 [entrez] PHST- 2022/05/04 06:00 [pubmed] PHST- 2022/05/04 06:01 [medline] PHST- 2022/05/03 00:00 [pmc-release] AID - 10.1186/s42836-022-00120-z [pii] AID - 120 [pii] AID - 10.1186/s42836-022-00120-z [doi] PST - epublish SO - Arthroplasty. 2022 May 3;4(1):18. doi: 10.1186/s42836-022-00120-z.